News

The Resident, Fellow and Student (RFS) Interventional Oncology Service Line’s latest educational resource focuses on the most widely adopted locoregional therapies for renal cell carcinoma (RCC) and serves as a companion to their December post on RCC disease overview and systemic therapies.

This resource, which is exclusive to medical students and residents, can be accessed within their SIR Connect community.